ClassID:

117134

C12Y305/01023 - CPC Classification

Classification description:

Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1) Ceramidase (3.5.1.23)

Recent Application in this class:
#1
20250228908
2025-07-17

TREATING ORTHOPEDIC INJURY WITH A VECTOR DRIVING EXPRESSION OF ACID CERAMIDASE

#2
20250188428
2025-06-12

NOVEL IN VITRO AND IN VIVO ENRICHMENT STRATEGY TARGETING LYMPHOCYTES DERIVED FROM VECTOR TRANSDUCED HSCS FOR THERAPY OF DISORDERS

#3
20250186565
2025-06-12

CERAMIDE LEVELS IN THE TREATMENT AND PREVENTION OF INFECTIONS

#4
20250170225
2025-05-29

COMPOSITIONS AND METHODS FOR TREATING FARBER DISEASE

#5
20250144188
2025-05-08

THERAPEUTIC ACID CERAMIDASE COMPOSITIONS AND METHODS OF MAKING AND USING THEM

#6
20250018017
2025-01-16

CERAMIDASE AND CELL DIFFERENTIATION

#7
20240075113
2024-03-07

COMPOSITIONS AND METHODS FOR TREATING FARBER DISEASE

#8
20230332112
2023-10-19

Novel In Vitro and In Vivo Enrichment Strategy Targeting Lymphocytes Derived from Vector Transduced HSCS for Therapy of Disorders

#9
20230265410
2023-08-24

CELL LINES, SYSTEMS, KITS, AND METHODS FOR DETERMINING THE SPECIFICITY AND/OR POTENCY OF CERAMIDASE INHIBITORS

#10
20230151390
2023-05-18

VECTORS FOR THE TREATMENT OF ACID CERAMIDASE DEFICIENCY

#11
20230091731
2023-03-23

COMPOSITIONS AND METHODS FOR INHIBITING ASAH1 GENE EXPRESSION

#12
20220313800
2022-10-06

COMPOSITIONS AND METHODS FOR TREATING FARBER DISEASE

#13
20220288004
2022-09-15

TREATMENT AND PREVENTION OF AGING RELATED-DISEASE AND/OR AGING BY THE INHIBITION OF SPHINGOLIPIDS

#14
20220202919
2022-06-30

CERAMIDE LEVELS IN THE TREATMENT AND PREVENTION OF INFECTIONS

#15
20210244827
2021-08-12

ANC80 ENCODING SPHINGOLIPID-METABOLIZING PROTEINS

#16
20210199670
2021-07-01

FARBER DISEASE MARKERS AND USES THEREOF

#17
20210002668
2021-01-07

SPHINGOLIPID-METABOLIZING PROTEINS ENHANCE THE EFFICIENCY OF GENE EDITING IN CELLS

#18
20210000975
2021-01-07

MODRNA ENCODING SPHINGOLIPID-METABOLIZING PROTEINS

#19
20200268686
2020-08-27

Sphingoid compounds for prophylaxis and/or therapy of a viral infection

#20
20200197457
2020-06-25

Oncolytic virus for expression of immune checkpoint modulators

#21
20200181582
2020-06-11

and enrichment strategy targeting lymphocytes derived from vector transduced HSCs for therapy of disorders

#22
20200113850
2020-04-16

Sphingoid compounds for prophylaxis and/or therapy of a viral infection

#23
20200002696
2020-01-02

Anc80 encoding sphingolipid-metabolizing proteins for mitigating disease-induced tissue damage

#24
20190343936
2019-11-14

COMPOSITIONS AND METHODS FOR TREATING FARBER DISEASE

#25
20190321454
2019-10-24

CERAMIDASE AND CELL DIFFERENTIATION

#26
20190302126
2019-10-03

FARBER DISEASE MARKERS AND USES THEREOF

#27
20190231857
2019-08-01

Therapeutic acid ceramidase compositions and methods of making and using them

#28
20190151424
2019-05-23

CERAMIDE LEVELS IN THE TREATMENT AND PREVENTION OF INFECTIONS

#29
20180203024
2018-07-19

Method for the diagnosis of Farber's disease

#30
20180193436
2018-07-12

Therapeutic acid ceramidase compositions and methods of making and using them

#31
20180179563
2018-06-28

Method for producing sphingoid base or sphingolipid

#32
20170157188
2017-06-08

Oncolytic virus for expression of immune checkpoint modulators

#33
20170020998
2017-01-26

Ceramide levels in the treatment and prevention of infections

#34
20160038574
2016-02-11

Therapeutic acid ceramidase compositions and methods of making and using them

#35
20150306189
2015-10-29

Compositions and methods for inducing liver regeneration by administering hepatocyte-derived exosomes

#36
20150125439
2015-05-07

Ceramide levels in the treatment and prevention of infections

#37
20140287015
2014-09-25

Ceramidase and cell differentiation

#38
20080199450
2008-08-21

Acid ceramidase and mammalian cell survival

#39
20080050753
2008-02-28

Antibody that binds ceramidase

#40
20060024809
2006-02-02

Ceramidase gene